| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
258 |
254 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
242 |
209 |
$1K |
| 87481 |
|
330 |
323 |
$736.90 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
344 |
334 |
$442.15 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
321 |
315 |
$147.40 |
| 87511 |
|
319 |
314 |
$147.40 |
| 87640 |
|
330 |
323 |
$147.40 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
250 |
246 |
$29.48 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
259 |
255 |
$29.48 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
248 |
204 |
$23.46 |
| 87529 |
|
155 |
153 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
232 |
190 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
18 |
$0.00 |